Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]
Keyword(s):
2016 ◽
Vol 48
(4)
◽
pp. 360-370
◽
Keyword(s):
2019 ◽
Vol 50
(11-12)
◽
pp. 1204-1213
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 9
(suppl 1)
◽
pp. S279-S279
◽
2018 ◽
Vol 12
(supplement_1)
◽
pp. S074-S074
Keyword(s):
2021 ◽
Vol Publish Ahead of Print
◽